The ADD3 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT-29 human colorectal adenocarcinoma cell line. This heterogeneous pool of edited cells abrogates functional expression of ??-adducin, providing a robust model for loss-of-function investigations. The polyclonal format captures a range of CRISPR-induced gene disruption events, reflecting the diversity of editing outcomes without selecting a single clonal derivative.
HT-29 is a well-characterized epithelial cell line established from a primary colon adenocarcinoma, harboring a p53 hotspot mutation (R273H). These cells display typical epithelial morphology with apical microvilli and tight junctions, and they retain the capacity to undergo enterocytic differentiation upon post-confluence or treatment with inducers such as sodium butyrate. Due to their origin and behavior, HT-29 cells serve as a widely adopted model for colorectal cancer biology, particularly for studying adhesion, polarity, and the epithelial-to-mesenchymal transition.
ADD3 codes for ??-adducin, a constituent of the heteromeric adducin complex that bridges spectrin and filamentous actin (F-actin) at the cortical cytoskeleton. Together with ??-adducin (ADD1) and ??-adducin (ADD2), ??-adducin stabilizes cell-cell junctions by recruiting the tight junction scaffold ZO-1 (TJP1). Its activity is tightly controlled by upstream signals including calmodulin, protein kinase C (PKC), and RhoA/ROCK-mediated phosphorylation, which modulate its affinity for spectrin and actin. Through these interactions, ??-adducin integrates pathways such as Rap1 signaling and actin cytoskeleton regulation to maintain epithelial integrity and restrict cell motility. ADD3 knockout therefore disrupts the adducin-spectrin-actin network, impairing junctional anchorage and promoting a more migratory phenotype.
In the HT-29 context, loss of ??-adducin is particularly informative because these cells rely on strong intercellular adhesion for their epithelial architecture. The knockout polyclonal population offers a direct means to examine how cytoskeletal disorganization affects colorectal cancer cell behavior. This model mirrors molecular alterations observed in pathologies linked to ADD3, including neural tube defects and cerebral cavernous malformations, where compromised cell adhesion is a common feature. By comparing the polyclonal pool to parental HT-29 cells, researchers can explore the functional impact of ADD3 disruption on tight junction integrity, actin dynamics, and the balance between adhesion and migration.
A variety of experimental approaches can leverage this knockout model. Immunofluorescence localization of F-actin and ZO-1, combined with wound healing and transwell migration assays, provides quantitative and visual assessments of cytoskeletal and motility changes. Cell adhesion assays and co-immunoprecipitation experiments enable dissection of the molecular interactions within the adducin-spectrin complex. RT-qPCR and Western blotting confirm ADD3 disruption, while phosphorylation analysis reveals alterations in regulatory inputs from PKC or RhoA/ROCK. Such studies are valuable for dissecting the cross-talk between p53 mutations and cytoskeletal remodeling in colon cancer, as well as for screening small molecules that target cell adhesion or migration pathways. For further information, please contact Ascent Research.
